ISSN 2147-9720 | E-ISSN 2148-4279
Case Report
An unusual manifestation in a patient with adult-onset Still’s disease: Minimal glomerular lesion
(Eur J Rheumatol 2014; 1: 123-124)
DOI: 10.5152/eurjrheumatol.2014.027
Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator
(Eur J Rheumatol 2017; 4: 288-290)
DOI: 10.5152/eurjrheum.2017.16112
Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis
(Eur J Rheumatol 2018; 5: 75-78)
DOI: 10.5152/eurjrheum.2016.15081
Original Article
Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet’s disease
(Eur J Rheumatol 2018; 5: 9-15)
DOI: 10.5152/eurjrheum.2017.17068
Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone
(Eur J Rheumatol 2014; 1: 147-149)
DOI: 10.5152/eurjrheumatol.2014.140074
Key Words
Author’s Corner
AVES | Copyright © 2018 Medical Research and Education Association | Latest Update: 27.11.2018